Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.47M Sell
37,190
-439
-1% -$50.7K 0.15% 132
2025
Q4
$3.96M Buy
37,629
+2,319
+7% +$218K 0.14% 145
2025
Q3
$2.96M Buy
35,310
+18,843
+114% +$1.55M 0.1% 182
2025
Q2
$1.3M Sell
16,467
-38,049
-70% -$3.02M 0.05% 286
2025
Q1
$4.89M Buy
54,516
+11,506
+27% +$1.07M 0.21% 103
2024
Q4
$4.28M Sell
43,010
-2,921
-6% -$301K 0.32% 79
2024
Q3
$5.22M Sell
45,931
-1,821
-4% -$216K 0.4% 54
2024
Q2
$5.91M Sell
47,752
-3,670
-7% -$473K 0.48% 44
2024
Q1
$6.79M Buy
51,422
+14,974
+41% +$1.85M 0.6% 31
2023
Q4
$4.57M Buy
36,448
+415
+1% +$43.1K 0.43% 49
2023
Q3
$3.69M Buy
36,033
+2,870
+9% +$309K 0.41% 54
2023
Q2
$3.53M Sell
33,163
-10,182
-23% -$1.16M 0.39% 61
2023
Q1
$4.61M Sell
43,345
-8,780
-17% -$948K 0.49% 40
2022
Q4
$5.78M Buy
52,125
+989
+2% +$101K 0.68% 21
2022
Q3
$5.17M Buy
51,136
+6,123
+14% +$547K 0.63% 28
2022
Q2
$4.02M Buy
45,013
+6,177
+16% +$548K 0.48% 45
2022
Q1
$3.19M Buy
38,836
+1,433
+4% +$113K 0.37% 87
2021
Q4
$2.99M Buy
+37,403
New +$2.98M 0.38% 88

Other funds holding MRK

Ascent Group's MRK Position: Q1 2026 in Review

Ascent Group reduced its Merck (MRK) stake by 1.2% in Q1 2026, selling an estimated $50.7K and leaving 37,190 shares worth $4.47M. The position accounts for 0.15% of the portfolio, ranked #132.

Ascent Group first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.79M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Ascent Group held 37,190 shares of Merck worth $4.47M as of Q1 2026.
  • Ascent Group sold 439 Merck shares in Q1 2026, an estimated $50.7K.
  • Merck made up 0.15% of Ascent Group's portfolio in Q1 2026, its #132 holding.
  • Ascent Group first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • Ascent Group's Merck position peaked at $6.79M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.